Affiliation: University of Iowa
- Anticoagulation: new challenges, old drugsBrian Olshansky
Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, 4426A JCP, Iowa City, IA 52242, USA
Curr Cardiol Rep 7:359-61. 2005....
- Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION TrialBrian Olshansky
University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
Heart Rhythm 9:34-9. 2012..The influence of PR prolongation on outcomes after cardiac resynchronization therapy (CRT) is uncertain...
- Survival After Rate-Responsive Programming in Patients With Cardiac Resynchronization Therapy-Defibrillator Implants Is Associated With a Novel Parameter: The Heart Rate ScoreBrian Olshansky
From the Mercy Hospital, Mason City, IA B O ProMedica Cardiology, Toledo, OH M R Boston Scientific, St Paul, MN A S, N W, P J, D P and Cleveland Clinic, Cleveland, OH B L W
Circ Arrhythm Electrophysiol 9:. 2016..The heart rate score (HRSc), an indicator of heart rate variation, may predict survival. We hypothesized that high-risk HRSc CRT-D patients will have improved survival with DDDR versus DDD alone...
- Conventional management of inappropriate sinus tachycardiaBrian Olshansky
University of Iowa Hospitals and Clinics, 200 Hawkins Drive, 4426A JCP, Iowa City, IA, 52242, USA
J Interv Card Electrophysiol 46:43-5. 2016..Inappropriate sinus tachycardia is a challenging problem to manage. There are limited data on the best method to evaluate and treat the problem. Here, we consider a conventional approach to inappropriate sinus tachycardia. ..
- SyncopePamela Nerheim
Division of Cardiology, The University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, IA 52242 1081, USA
Curr Treat Options Cardiovasc Med 3:299-310. 2001..The great challenge of treating patients with syncope is to provide cost-effective, safe therapy to those with a benign course and still provide needed treatment for those whose syncope is life threatening...
- Rate versus rhythm control strategies for AFBrian Olshansky
Division of Cardiology, University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, IA 52242, USA
Curr Treat Options Cardiovasc Med 7:371-81. 2005....
- Syncope in Patients with Organic Heart DiseaseBrian Olshansky
University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, IA 52242, USA Electronic address
Cardiol Clin 33:449-63. 2015..The goal is to reduce the risk of further syncope, to improve long-term outcomes with respect to arrhythmic and total mortality, and to improve patients' quality of life. ..
- Vagus nerve modulation of inflammation: Cardiovascular implicationsBrian Olshansky
Cardiac Electrophysiology, University of Iowa Hospitals, Iowa City, IA Electronic address
Trends Cardiovasc Med 26:1-11. 2016..Here, evidence for and components of the vagus inflammatory reflex are reviewed and evidence for and implications of effects of vagus activation on inflammation in the cardiovascular system are considered. ..
- Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillationRenee M Sullivan
Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
Core Evid 5:49-59. 2010..Dronedarone, a benzofuran derivative with a structure similar to amiodarone, has been developed as a potential therapy for patients with atrial fibrillation...
- Increased prevalence of atrial fibrillation in the endurance athlete: potential mechanisms and sport specificityBrian Olshansky
Professor Emeritus, University of Iowa Hospitals, Iowa City and Mercy Hospital, Mason City, IA
Phys Sportsmed 42:45-51. 2014..Finally, we consider some of the options that are available to treat athletes who develop atrial fibrillation. ..
- Sudden death risk in syncope: the role of the implantable cardioverter defibrillatorBrian Olshansky
University of Iowa Hospitals, Iowa City, IA 52242, USA
Prog Cardiovasc Dis 55:443-53. 2013..This review focuses on the sudden death risk in patients with syncope and explores the role of the ICD to treat ventricular arrhythmias, prevent symptoms, and prevent death...
- Inappropriate sinus tachycardiaBrian Olshansky
Department of Internal Medicine, Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA
J Am Coll Cardiol 61:793-801. 2013..Overtreatment, in an attempt to reduce symptoms, can be difficult to avoid, but is discouraged...
- Interrelationships between the autonomic nervous system and atrial fibrillationBrian Olshansky
Department of Internal Medicine, University of Iowa Hospitals, Iowa City, IA 52242, USA
Prog Cardiovasc Dis 48:57-78. 2005..This article reviews what is known regarding the inter-relationships between the autonomic nervous system and atrial fibrillation and provides state of the art information at all levels of autonomic interactions...
- Use of amiodarone for atrial fibrillation in patients with preexisting pulmonary disease in the AFFIRM studyBrian Olshansky
University of Iowa, Iowa City, Iowa, USA
Am J Cardiol 95:404-5. 2005..Cautious use of amiodarone to treat atrial fibrillation appears acceptable in elderly patients with atrial fibrillation, even if preexisting pulmonary disease is present...
- Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) studyBrian Olshansky
University of Iowa Hospitals, 200 Hawkins Drive, Iowa City, IA 52242, USA
J Am Coll Cardiol 45:2026-33. 2005..The purpose of this study was to evaluate the associations of transthoracic echocardiographic parameters with recurrent atrial fibrillation (AF) and/or stroke...
- Acute anticoagulation adjustment in patients with atrial fibrillation at risk for stroke: approaches, strategies, risks and benefitsBrian Olshansky
Cardiac Electrophysiology, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Drive, Iowa City, IA 52242, USA
Expert Rev Cardiovasc Ther 3:571-90. 2005..This analysis provides practical recommendations based on available data and presents results from recent investigations that may provide insight into future strategies...
- Inhibition of Unnecessary RV Pacing with AV Search Hysteresis in ICDs (INTRINSIC RV): design and clinical protocolBrian Olshansky
University of Iowa Hospitals, Iowa City, Iowa 52242, USA
Pacing Clin Electrophysiol 28:62-6. 2005..Patients are followed for one year. This large, randomized, controlled, clinical trial will address whether DDDR with AVSH programming is equivalent to VVI programming in an ICD with regard to mortality and heart failure hospitalization...
- Location of death (in-hospital or out-of-hospital) and type of death (arrhythmic, nonarrhythmic, noncardiac) after inducible sustained ventricular tachyarrhythmias after syncope, sustained ventricular tachycardia, or nonfatal cardiac arrest (the ESVEM triB Olshansky
University of Iowa Hospitals, Iowa City, Iowa, USA
Am J Cardiol 86:846-51. 2000..Thus, over half the deaths in the ESVEM trial occurred in-hospital. The long-term actuarial risk of out-of-hospital arrhythmic death in ESVEM was unexpectedly low...
- Fast-track training of nonelectrophysiologists to implant defibrillators: is it needed?Brian Olshansky
University of Iowa School of Medicine, Iowa City, Iowa, USA
Pacing Clin Electrophysiol 29:627-31. 2006..We are particularly concerned about the disruption of training pathways in medicine and how this can affect patient care and can influence established training pathways in medicine...
- Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (Inhibition of Unnecessary RV Pacing With AVSH in ICDs) studyBrian Olshansky
University of Iowa Hospitals, 200 Hawkins Dr, Iowa City, IA 52242, USA
Circulation 115:9-16. 2007....
- Placebo and nocebo in cardiovascular health: implications for healthcare, research, and the doctor-patient relationshipBrian Olshansky
Cardiac Electrophysiology, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Drive, Iowa City, Iowa 52242, USA
J Am Coll Cardiol 49:415-21. 2007..Healthcare, rendered by a faceless, uncaring army of protocol aficionados, will miss an opportunity to deliver an effective placebo response. Wise placebo use can benefit patients and strengthen the medical profession...
- Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Brian Olshansky
Department of Internal Medicine, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Dr, Iowa City, IA 52242, USA
Am Heart J 153:1089-94. 2007..In the SCD-HeFT, mortality of patients with CHF was assessed after randomization to an implantable cardioverter/defibrillator (ICD), amiodarone, or placebo. The aim of this study was to evaluate the location of deaths in SCD-HeFT...
- Eliminating right ventricular pacing may not be best for patients requiring implantable cardioverter-defibrillatorsBrian Olshansky
University of Iowa Hospitals, Iowa City, IA 52242, USA
Heart Rhythm 4:886-91. 2007..It remains uncertain how much RV pacing is clinically deleterious...
- Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT studyBrian Olshansky
University of Iowa, Iowa City, Iowa, USA
J Am Coll Cardiol 51:1277-82. 2008..The outcome of congestive heart failure (CHF) patients with syncope is understood incompletely...
- Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapyBrian Olshansky
Division of Cardiology, University of Iowa Hospitals, 200 Hawkins Dr 4426a JCP, Iowa City, IA 52242, USA
Circulation 118:863-71. 2008
- Differential pharmacological effects of antimuscarinic drugs on heart rate: a randomized, placebo-controlled, double-blind, crossover study with tolterodine and darifenacin in healthy participants > or = 50 yearsBrian Olshansky
University of Iowa Hospitals, Iowa City, Iowa 52242, USA
J Cardiovasc Pharmacol Ther 13:241-51. 2008..0114) but did not differ between darifenacin and placebo. The results show that antimuscarinics exert differential effects on heart rate depending on their muscarinic receptor profile. This should be considered when selecting a treatment...
- Implantable cardioverter defibrillator practices and costs at an academic medical centerB Olshansky
Loyola University Medical Center, Maywood, Illinois, USA
J Cardiovasc Electrophysiol 12:162-6. 2001..In the cost-to-charge ratio analysis, the mean costs for the inpatient hospitalization were $35,623. This is one of the first studies to document cost of ICD therapy and may serve as a benchmark for other facilities...
- Alternative medicine--boom or bust?Brian Olshansky
The Section of Electrophysiology, Division of Cardiology, The University of Iowa Hospitals, Iowa City, IA 52242, USA
Card Electrophysiol Rev 6:170-3. 2002
- Retroactive prayer: a preposterous hypothesis?Brian Olshansky
University of Iowa Hospitals, Iowa City, IA, USA
BMJ 327:1465-8. 2003
- The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillationBrian Olshansky
University of Iowa, Iowa City, Iowa 52242, USA
J Am Coll Cardiol 43:1201-8. 2004..We sought to evaluate approaches used to control rate, the effectiveness of rate control, and switches from one drug class to another in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study...
- The impact of atrial prevention and termination therapies on atrial tachyarrhythmia burden in patients receiving a dual-chamber defibrillator for ventricular arrhythmiasPaul A Friedman
Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA
J Interv Card Electrophysiol 10:103-10. 2004....
- Apparent bidirectional conduction block following radiofrequency catheter ablation of typical atrial flutterR F Quintos
Loyola University Medical Center, Maywood, Illinois, USA
J Interv Card Electrophysiol 5:109-18. 2001..The purpose of this study is to determine the reliability of activation sequence mapping in assessing the presence of bidirectional conduction block (BCB) in typical atrial flutter (AFL) ablation...
- Cardioversion of atrial tachyarrhythmias: anticoagulation to reduce thromboembolic complicationsHongsheng Guo
University of Iowa Hospital, Iowa City, 52242, USA
Prog Cardiovasc Dis 46:487-505. 2004
- Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortalityT Jared Bunch
Department of Internal Medicine, Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA
Heart Rhythm 6:2-8. 2009..Atrial fibrillation (AF) has been associated with higher rates of all-cause mortality in patients with heart failure (HF). The risk of newly detected AF in patients receiving implantable cardioverter-defibrillator (ICD) therapy is unknown...
- Syncope in congestive heart failureRakesh Gopinathannair
Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
Cardiol J 15:303-12. 2008
- Outpatient cardioversion of atrial arrhythmias: efficacy, safety, and costsSally Birger Botkin
Loyola University Chicago, Medical Center, Maywood, Ill, USA
Am Heart J 145:233-8. 2003..Outpatient direct current (DC) cardioversion is performed routinely, yet scant data support this approach. We studied the efficacy, safety, and costs of outpatient cardioversion...
- Temporary biventricular pacing in a patient with subacute myocardial infarction, cardiogenic shock, and third-degree atrioventricular blockHongsheng Guo
University of Iowa Hospital, 52242, USA
Heart Rhythm 2:112. 2005
- Unusual response to atrial extrastimulus testingStuart D Christenson
Cardiac Electrophysiology Section, Department of Medicine, University of Iowa Hospitals and Clinics, Iowa City 52242 1081, USA
J Cardiovasc Electrophysiol 13:200. 2002
- Early versus late atrial fibrillation after atrial flutter ablationEmmanuel Loutrianakis
Loyola University Medical Center, 2160 S First Ave, Maywood, IL 60153, USA
J Interv Card Electrophysiol 6:173-80. 2002..Atrial fibrillation (AFib) after radiofrequency catheter ablation of AFl can occur but may be transient (lasting no more than four weeks)...
- Not so innocent bystander(s)Rakesh Gopinathannair
Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, E 318 5 GH, 200 Hawkins Drive, Iowa City, IA 52242, USA
Europace 11:1230-4. 2009..This was due to antidromic AV re-entrant tachycardia with innocent bystander activation of the right atrium mimicking atrial flutter. Accessory pathway ablation effectively stopped tachycardia...
- Tachycardia-mediated cardiomyopathy: recognition and managementRakesh Gopinathannair
University of Iowa Hospitals, 200 Hawkins Drive, 4426A JCP, Iowa City, IA 52242, USA
Curr Heart Fail Rep 6:257-64. 2009....
- Reduction of right ventricular pacing in patients with dual-chamber ICDsBrian Olshansky
University of Iowa Hospitals, Iowa City, Iowa 52242, USA
Pacing Clin Electrophysiol 29:237-43. 2006....
- Update on medical management of atrial fibrillation in the modern eraRakesh Gopinathannair
Division of Cardiovascular Medicine, University of Iowa Hospitals, Iowa City, Iowa 52242, USA
Heart Rhythm 6:S17-22. 2009..This review updates the present state-of-the-art regarding medical management of atrial fibrillation based on present and emerging evidence...
- Irregular atrial activation during atrioventricular nodal reentrant tachycardia: evidence of an upper common pathwayHongsheng M Guo
University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242, USA
J Cardiovasc Electrophysiol 14:309-13. 2003..Our observations support the concept of an upper common pathway, at least in some patients with AV nodal reentrant tachycardia...
- Heart rate predicts outcomes in an implantable cardioverter-defibrillator populationMastaneh Ahmadi-Kashani
Department of Medicine, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Dr, Iowa City, IA 52242, USA
Circulation 120:2040-5. 2009..Our hypothesis was that mean HR predicts total mortality and heart failure hospitalization in patients undergoing implantable cardioverter-defibrillator (ICD) implantation...
- Implantable defibrillator use for de novo ventricular tachyarrhythmias encountered after cardiac surgeryEdward A Telfer
University of Iowa Hospitals, Iowa City 52242, USA
Pacing Clin Electrophysiol 25:951-6. 2002..6 +/- 7.8 months and 10.5 months, respectively. De novo postoperative ventricular arrhythmias are associated with a high probability of late recurrence. The ICD is useful for these patients...
- Bolus isoproterenol infusions provide a reliable method for assessing interoceptive awarenessS S Khalsa
Neuroscience Graduate Program, Department of Neurology, University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA
Int J Psychophysiol 72:34-45. 2009....
- Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyJonathan S Steinberg
Division of Cardiology, St Luke s Roosevelt Hospital Center and Columbia University, New York, NY 10025, USA
Circulation 109:1973-80. 2004..This report describes the cause-specific modes of death in the AFFIRM treatment groups...
- Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardiaPamela Nerheim
University of Iowa Hospitals, Iowa City, IA 52242 1081, USA
Circulation 110:247-52. 2004....
- Ventricular tachycardia with QRS configuration similar to that in sinus rhythm and a myocardial origin: differential diagnosis with bundle branch reentryH Guo
Department of Medicine, Loyola University Medical Center, Maywood, Illinois, USA
Europace 3:115-23. 2001..Although it mimics usual bundle branch reentry, this form of ventricular tachycardia appears to be due to a different mechanism in which the His bundle is not obligatory for the continuation of the reentrant phenomenon...
- Antiarrhythmic effects of statins in heart failureChirag M Sandesara
University of Iowa Hospitals and Clinics, Iowa City, IA, USA
Heart Fail Clin 4:187-200. 2008..Ongoing and future clinical trials will likely resolve the discrepancies between studies and further the understanding of how pleiotropic properties of statins can be antiarrhythmic in patients who have heart failure...
- Pericarditis in myasthenia gravisHemender S Vats
Department of Internal Medicine, University of Iowa Hospitals and Clinics Iowa City, Iowa, USA
Cardiol Rev 12:134-7. 2004..We report the presence of pericardial effusion and atrioventricular conduction block in a patient with myasthenia gravis that responded appropriately to immunosuppressive therapy and plasma exchanges...
- Hope for a better worldBrian Olshansky
Division of Cardiology, Department of Internal Medicine, University of Iowa Health Care, Iowa City, IA 52242, USA
Cardiol Rev 11:306-8. 2003
- Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-IIAnant K Vyas
Heart Research Follow up Program of the Cardiology Unit of the Department of Medicine, University of Rochester Medical Center, Rochester, New York 14642, USA
J Am Coll Cardiol 47:769-73. 2006....
- Advances in atrial flutter mapping: what goes around comes aroundBrian Olshansky
J Cardiovasc Electrophysiol 15:415-7. 2004
- Addendum to the clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devicesJohn D Day
Utah Cardiovascular Research Institute, Utah Heart Clinic, LDS Hospital, Salt Lake City, Utah, USA
Heart Rhythm 2:1161-3. 2005
- Electrophysiological characterization of cardiac veins in humansDavid A Cesario
UCLA Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles CA
J Interv Card Electrophysiol 10:241-7. 2004..The purpose of this study was to evaluate the electrical activity of the coronary sinus (CS), great cardiac vein (GCV) and related structures, such as the Vein of Marshall (VOM)...
- Is the approach to atrial fibrillation ablation becoming more complex and fractionated?Brian Olshansky
Heart Rhythm 3:35-6. 2006
- Patterns and predictors of warfarin use in patients with new-onset atrial fibrillation from the FRACTAL RegistryMatthew R Reynolds
Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Am J Cardiol 97:538-43. 2006..The discontinuation of warfarin in a large number of patients with AF over time is a cause for concern in light of data from recent clinical trials...
- Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studiesIsabelle C Van Gelder
Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, PO Box 30 001, 9700 RB Groningen, The Netherlands
Europace 8:935-42. 2006..The AFFIRM and RACE studies showed that rate control is an acceptable treatment strategy for atrial fibrillation (AF). We examined whether strict rate control offers benefit over more lenient rate control...
- Wide QRS, narrow QRS: what's the difference?Brian Olshansky
J Am Coll Cardiol 46:317-9. 2005
- Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillationVidal Essebag
Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada
Arch Intern Med 167:1648-53. 2007..The aims of this study were to determine prospectively whether amiodarone increases the need for pacemakers in a general population of patients with AF and whether this effect is modified by sex...
- Combining ablation of atrial fibrillation with ablation of atrial flutter: are we there yet?Brian Olshansky
J Am Coll Cardiol 43:2063-5. 2004
- A practical guide for clinicians who treat patients with amiodarone: 2007Nora Goldschlager
University of California, San Francisco, California, USA
Heart Rhythm 4:1250-9. 2007..The recommendations included herein are based on the best available data and the collective experience of the member of the writing committee...
- Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Michael G Dickinson
Thoracic Cardiovascular Institute Foundation, Lansing, MI, USA
Am Heart J 153:573-8. 2007..The study length, size, and degree of background HF, including the use of implantable defibrillator therapy, provide a unique opportunity to evaluate the impact of statin use in HF with mechanistic insights from subgroup analyses...
- Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and InJohn H K Vogel
J Am Coll Cardiol 46:184-221. 2005
- High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systemsJohn D Day
Utah Heart Clinic Arrhythmia Services, LDS Hospital, 324 10th Avenue, Suite 206, Salt Lake City, UT 84103, USA
Europace 10:347-50. 2008..Little data are available on the number of patients who do not have a 10 J margin initially and therefore require system revisions, further testing, or a higher energy output device...
- Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillationPeter Zimetbaum
Cardiovascular Division, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Clinical Research Institute, Boston, Massachusetts 02215, USA
Am J Cardiol 91:81-3. 2003
- The "pill-in-the-pocket" approach to atrial fibrillationSuma H Konety
N Engl J Med 352:1150-1; author reply 1150-1. 2005
- Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerationsKarl Erik Andersson
Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA
BJU Int 100:1007-14. 2007..This is without doubt the most detailed and the most reader-friendly paper on this subject, and I am sure that it will help urologists to assist in further educating their patients when prescribing these compounds...
- Task Force 9: drugs and performance-enhancing substancesN A Mark Estes
J Am Coll Cardiol 45:1368-9. 2005
- Arrhythmias in tako-tsubo syndrome--benign or malignant?Suma H Konety
Int J Cardiol 114:141-4. 2007..We present a unique case of tako-tsubo syndrome in a 71-year-old woman who developed symptomatic ventricular arrhythmias after complete resolution of cardiomyopathy...
- High intensity anticoagulation for cardioversion of atrial arrhythmias? The shocking truthBrian Olshansky
J Am Coll Cardiol 40:934-6. 2002
- Etiologic considerations in the patient with syncope and an apparently normal heartNora Goldschlager
Cardiology Division, 1001 Potrero Ave, Room 5G1, San Francisco General Hospital, San Francisco, CA 94110, USA
Arch Intern Med 163:151-62. 2003
- Safety of sports participation in patients with implantable cardioverter defibrillators: a survey of heart rhythm society membersRachel Lampert
Yale University School of Medicine, Department of Medicine, New Haven, Connecticut 06520, USA
J Cardiovasc Electrophysiol 17:11-5. 2006..Safety of Sports for ICD Patients...
- Inadvertent positioning of pacemaker leads in the pericardiumKambeez Berenji
Department of Cardiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Pacing Clin Electrophysiol 26:2039-41. 2003..The lead position on chest X ray and the ECG pattern indicated lead malposition, but a CT scan and transesophageal echocardiography were nondiagnostic. Venography indicated that both leads were in the mediastinal and pericardial space...
- The ACCF/AHA scientific statement on syncope needs rethinkingDavid G Benditt
J Am Coll Cardiol 48:2598-9; author reply 2599. 2006
- Complementary and alternative medicine: the need for dataBrian Olshansky
Cardiol Rev 11:53-5. 2003